Akèy › Ensifizyans kadyak › Kalifòni › Chula Vista
Etid klinik pou Ensifizyans kadyak nan Chula Vista, CA
6 etid pou Ensifizyans kadyak ap chèche patisipan nan sit nan ak bò kote Chula Vista (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Ap rekriteFaz 3
- Velocity Clinical Research-Chula Vista, Chula Vista
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Ap rekriteFaz 3
- Chula Vista, CA Investigative Site 10111, Chula Vista
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Ap rekriteFaz 3
- Chula Vista, CA Investigative Site CON-10111, Chula Vista
NORM-HF Pivotal Study
Ap rekrite
- Cardiovascular Institute of San Diego, Chula Vista
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Ap rekriteFaz 3
- Scripps Hospital, Chula Vista
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
Ap rekriteFaz 3
- Chula Vista, CA Investigative Site FIN-10419, Chula Vista
- Chula Vista, CA Investigative Site FIN-10111, Chula Vista
Etid Ensifizyans kadyak nan lòt vil
- New York City, NY51 etid
- Boston, MA44 etid
- Dallas, TX42 etid
- Houston, TX36 etid
- Cleveland, OH33 etid
- Chicago, IL31 etid
- Philadelphia, PA31 etid
- San Francisco, CA29 etid
- Durham, NC26 etid
- St. Louis, MO26 etid
- Atlanta, GA25 etid
- Kansas City, MO25 etid
Lòt etid nan Chula Vista
- Dyabèt Tip 25 etid
- Obèsite4 etid
- Maladi kadyovaskilè4 etid
- Maladi atè koronè3 etid
- Dyabèt3 etid
- Sipwa3 etid
- Kolit Ulseratif3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.